The research, led by Solveig Løkhammer and Renato Polimanti of Yale School of Medicine together with colleagues at the University of Bergen and partner institutions across Europe and the United States, harnessed three of the largest biomedical databases in existence: the All of Us Research Program with 98,551 participants, the FinnGen Project with 377,277, and the Million Veteran Program with 449,042. Together these cohorts provided both genome-wide genetic data and longitudinal electronic health records, allowing the team to connect inherited variation with real clinical diagnoses across the human phenome. The scale matters. Childhood maltreatment is difficult to study directly, both because retrospective reports are imperfect and because the environmental and genetic factors that shape families are deeply intertwined. Genetic approaches offer a way to disentangle some of that tangle.

The centerpiece of the study was a phenome-wide association study, or PheWAS, of genetic variants previously linked to childhood maltreatment. Rather than asking whether one variant relates to one disease, a PheWAS flips the design: the researchers took the set of genetic loci associated with maltreatment liability and systematically tested them against thousands of coded medical outcomes in the health records of the three cohorts. The signal was striking. The maltreatment-associated loci showed associations with 66 distinct medical outcomes at a genome-wide significance threshold of p less than 2.76 × 10⁻⁶. The affected domains were broad, spanning psychiatric conditions, musculoskeletal disorders, circulatory disease, neurologic conditions and respiratory illness, suggesting that the genetic architecture of maltreatment risk is woven into many different systems of the body rather than confined to the brain.

To probe those relationships more deeply, the team turned to genetic correlation analysis, which estimates the degree to which two traits share the same underlying genetic influences across the entire genome. Here the picture became even richer: 285 significant genetic correlations with childhood maltreatment emerged at a threshold of p less than 3.24 × 10⁻⁵, again covering a wide range of medical domains. Among all of these, one relationship towered above the rest. Emotional disorders with onset during childhood or adolescence showed the highest genetic overlap with maltreatment liability, with a genetic correlation of 0.75. That figure implies a very substantial sharing of genetic influences between the liability to experience or report maltreatment and the liability to develop early-onset emotional disorders, a finding that resonates with long-standing clinical observations that abuse, anxiety and depression cluster within the same families and the same developmental windows.

Genetic correlation, however, cannot by itself tell us the direction of causation or whether the shared signal reflects a single causal variant or many. The researchers therefore deployed latent causal variable analysis, a method that uses the observed genetic correlations and their standard errors to distinguish genuine causality from confounding due to shared ancestry or overlapping variant effects. The LCV results pointed to genetic relationships between childhood maltreatment and musculoskeletal, metabolic, respiratory and eye-related outcomes, extending the story beyond psychiatry into physical health domains that are rarely discussed in the same breath as early adversity. The suggestion that maltreatment genetic liability travels with conditions affecting bones, joints, metabolism and vision adds a provocative new dimension to the biology of early-life stress.

The next question was whether these genetic relationships behave like causal effects, and the answer turned out to be complicated. Using bidirectional Mendelian randomization, a technique that uses genetic variants as natural instruments to test whether one trait influences another, the team found bidirectional and heterogeneous effects for the outcomes flagged by LCV. In other words, genetic instruments for maltreatment liability appeared to influence these health outcomes, but instruments for the outcomes also appeared to influence maltreatment liability, and the effects were not consistent across instruments. The authors interpret this pattern as possibly reflecting dynastic confounding, a subtle phenomenon in which the genotypes of parents and more distant ancestors shape the family environments into which children are born, blurring the line between inherited biology and inherited circumstance. In studies of parenting and childhood outcomes, dynastic effects are a serious methodological concern, and their presence here cautions against simple causal narratives.

Perhaps the most socially consequential finding came from the final layer of analysis. The researchers asked whether the genetic associations between childhood maltreatment and adult health might actually be carried, at least in part, by socioeconomic conditions, using household income as a proxy. Two complementary methods were applied: multi-trait conditional and joint analysis, which partitions genetic signal among correlated traits, and multivariate Mendelian randomization, which estimates the direct effect of one exposure while accounting for others that share its instruments. Both analyses converged on the same conclusion. When household income was taken into account, the effect of childhood maltreatment genetic liability on health outcomes was reduced. Socioeconomic factors, in other words, appear to explain a meaningful share of what had looked like a direct genetic relationship between early adversity and adult disease.

The authors are careful about what this does and does not mean. The finding does not suggest that maltreatment is benign, nor that its health consequences are illusory. Rather, it indicates that different pleiotropic mechanisms, in which the same genetic variants influence multiple traits, likely contribute to the observed relationships between maltreatment and several health domains, and that these relationships are at least partially explained by the socioeconomic contexts that shape both the risk of maltreatment and the trajectory of health across the life course. Genes, family income, neighborhood, and parenting behavior are not independent variables; they cascade through one another across generations. A study of this design cannot fully separate those strands, but it can measure how much of the apparent genetic signal survives when the socioeconomic strand is held steady, and here the answer is: less than the raw correlations implied.

For the field of trauma research, the study offers both a methodological template and a conceptual warning. The template is the integration of PheWAS, genetic correlation, latent causal variable analysis, and univariate and multivariate Mendelian randomization across multiple biobanks, a pipeline that interrogates the same question from several independent angles and reports where the answers agree and where they fracture. The warning is that observational associations between childhood adversity and adult disease, even those that appear in genetic data, can be shaped by dynastic and socioeconomic confounding in ways that standard adjustments do not capture. Interventions aimed at breaking the intergenerational cycle of maltreatment may need to target economic conditions as directly as they target parenting and mental health, because the two are genetically and environmentally entangled.

What emerges from this investigation is a portrait of childhood maltreatment as a genetically and socially embedded phenomenon whose fingerprints appear across psychiatric, musculoskeletal, circulatory, neurologic, respiratory, metabolic and even ocular health in adulthood. The strongest genetic overlap lies with emotional disorders beginning in childhood and adolescence, reinforcing the idea that the earliest years are a critical window in which liability to adversity and liability to emotional illness travel together. But the attenuation of maltreatment effects after accounting for household income is the finding with the clearest policy resonance: part of the long shadow of early adversity is cast not by biology alone but by the economic circumstances that surround a child. Disentangling those threads, the authors suggest, will require the continued growth of genetically informed cohorts and methods that can separate direct genetic effects from the inherited environments families pass down alongside their DNA.

Subject of Research: Genetic and socioeconomic mechanisms linking childhood maltreatment to adult health outcomes

Article Title: A genetically informed investigation into the relationship between childhood maltreatment and adult health

Article References: A genetically informed investigation into the relationship between childhood maltreatment and adult health. (n.d.). https://doi.org/10.1038/s41398-026-04498-1

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04498-1

Keywords: childhood maltreatment, genetics, PheWAS, Mendelian randomization, genetic correlation, socioeconomic factors, household income, psychiatric disorders, Translational Psychiatry, All of Us, FinnGen, Million Veteran Program

The CALLY index first attracted attention in surgical oncology, where studies of patients undergoing gastrectomy for gastric cancer, hepatectomy for colorectal liver metastases and surgery for oral cavity and breast cancers showed that the measure carried prognostic significance for outcomes. Its appeal lies in its elegant simplicity. The index integrates three routinely measured blood components that capture distinct dimensions of a person’s internal physiology: C-reactive protein, an acute-phase protein produced by the liver that rises rapidly during systemic inflammation; albumin, the most abundant plasma protein, whose concentration reflects nutritional status, liver synthetic function and the degree of chronic inflammatory suppression; and the lymphocyte count, a readout of adaptive immune competence. By combining inflammation, nutrition and immunity into a single number, the CALLY index offers a panoramic snapshot of the body’s systemic state that no single biomarker can provide.

What has remained unclear, however, is whether the index merely correlates with disease or whether it plays some causal role in disease development. Observational associations are notoriously vulnerable to reverse causation and confounding. A patient with early neurodegeneration may have poor nutrition and chronic inflammation as consequences of the disease process rather than contributors to it. To cut through this ambiguity, the research team, led by investigators at Soochow University in Suzhou, China, turned to Mendelian randomization, a technique that exploits the random allocation of genetic variants at conception as a form of natural experiment. Because genetic variants inherited from parents are fixed at birth and generally unaffected by later disease processes, they can serve as proxies for a lifelong exposure, allowing researchers to test whether the exposure itself influences disease risk rather than the reverse.

The scale of the underlying data is central to the study’s power. The team first conducted a genome-wide association study of the CALLY index in 265,409 UK Biobank participants, scanning millions of genetic variants across the genome for statistical associations with the composite measure. This effort identified 154 genomic loci significantly associated with the index, providing a rich set of genetic instruments. The loci implicated genes involved in hepatic acute-phase responses, immune cell regulation and metabolic pathways, which is consistent with the three biological pillars the index is designed to capture. The breadth of the signal also confirmed that the CALLY index has a substantial and distributed genetic architecture, a prerequisite for reliable Mendelian randomization analysis.

With the genetic instruments in hand, the researchers performed a phenome-wide association study, or PheWAS, across 713 phenotypes in 113,747 UK Biobank participants. Rather than asking whether one biomarker predicts one disease, a PheWAS inverts the question and asks whether the genetically predicted biomarker is associated with any condition across the entire recorded spectrum of human illness. This agnostic screening approach is designed to surface unexpected connections that hypothesis-driven studies would never think to test. Out of the 713 phenotypes examined, 24 showed statistically significant associations with the genetically predicted CALLY index, a yield that is striking given the stringency of the multiple-testing corrections applied in such analyses.

The most consequential of these associations involved the neurodegenerative outcomes. Higher genetically predicted CALLY index values were linked to lower risks of Alzheimer’s disease, Alzheimer’s dementia and unspecified dementia, and the two-sample Mendelian randomization analysis confirmed these as causal protective effects rather than mere correlations. This finding dovetails with a growing body of evidence implicating systemic inflammation and immune dysfunction in Alzheimer’s pathogenesis. The blood-brain barrier, once viewed as an impenetrable fortress protecting the central nervous system, is now known to be permeable to inflammatory signals arising from systemic infection and chronic low-grade inflammation. Peripheral inflammatory activity can modulate microglial activation within the brain, influence amyloid-beta clearance and shape the trajectory of neurodegeneration. An index that integrates inflammatory burden, nutritional reserve and adaptive immune capacity may therefore capture, in a single measure, several converging pathways that influence the brain’s resilience against degenerative disease.

The metabolic findings reinforce this systems-level interpretation. The PheWAS and subsequent causal analyses linked higher CALLY index values to lower risks of lipid metabolism disorders, and pleiotropy analyses pointed to shared biological pathways in lipid metabolism and inflammation connecting the index to its disease outcomes. Chronic low-grade inflammation is a well-established feature of obesity, insulin resistance and dyslipidemia, and inflammatory cytokines released from adipose tissue can perturb hepatic lipid handling and accelerate atherosclerotic processes. Albumin, meanwhile, is a major carrier protein for fatty acids and other lipophilic molecules in the circulation, and its concentration is sensitive to both nutritional intake and inflammatory catabolism. The convergence of these signals suggests that the CALLY index functions as a barometer of the inflammatory-metabolic axis, a physiological axis whose dysfunction is increasingly recognized as a common root of multiple chronic diseases of aging.

Not every association in the study was reassuring. The Mendelian randomization analysis indicated a causal association between higher genetically predicted CALLY index and increased risk of sleep disorders, a finding that adds an intriguing and cautionary dimension to the biomarker’s profile. Sleep disturbance is itself tightly intertwined with inflammation and immune function; insufficient or fragmented sleep elevates inflammatory markers, while chronic inflammation disrupts the hypothalamic circuits that regulate circadian rhythm. The direction of the observed association, in which a more favorable inflammatory-nutritional-immune profile paradoxically accompanies greater sleep disorder risk, will require further investigation to disentangle. It may reflect shared genetic pathways, compensatory physiological responses or pleiotropic effects of the instrument variants that influence both the index and sleep biology through independent routes. The authors addressed this concern with a battery of sensitivity analyses, including linkage disequilibrium score regression and pleiotropy testing, designed to detect and correct for horizontal pleiotropy, the phenomenon in which genetic variants affect outcomes through pathways other than the exposure of interest.

The methodological rigor underpinning these conclusions deserves emphasis. Two-sample Mendelian randomization relies on three core assumptions: the genetic instruments must be strongly associated with the exposure, must not be confounded by population stratification or other environmental factors, and must influence the outcomes only through the exposure. Violations of the third assumption, known as pleiotropy, are the principal threat to validity, and the study deployed multiple complementary tests, including Egger regression-based approaches, to detect directional pleiotropic bias. The use of two independent data sources, with the UK Biobank supplying the exposure and outcome data and FinnGen providing replication material, further strengthens the case that the observed causal signals are not artifacts of a single cohort’s idiosyncrasies. The ethical framework of the underlying resource was also robust, with approval from the Northwest Multi-center Research Ethics Committee and informed consent from all participants.

The practical implications extend beyond the laboratory. Because the CALLY index is computed from three tests that are already part of standard clinical blood panels, it could be incorporated into risk prediction models at essentially no additional cost. If future prospective studies validate the causal relationships reported here, the index could help clinicians identify individuals whose inflammatory-nutritional-immune profile places them at elevated risk of dementia or metabolic disease decades before symptoms emerge, opening a window for preventive interventions targeting inflammation, nutrition and immune health. At the same time, the sleep disorder finding is a reminder that systemic physiology is a web of trade-offs rather than a simple gradient from good to bad. The study’s authors, supported by funding from the Natural Science Foundation of China, frame the CALLY index as a promising integrated biomarker for disease risk stratification and public health applications, and this phenome-wide genetic analysis provides the strongest evidence yet that the number scrawled on a routine lab report may quietly encode a person’s vulnerability to some of the most burdensome diseases of our time.

Subject of Research: Causal associations between the CRP–albumin–lymphocyte (CALLY) index and multisystem human diseases using phenome-wide Mendelian randomization

Article Title: CRP–albumin–lymphocyte index and multisystem diseases: a phenome-wide Mendelian randomization study

Article References: Niu, B., Xia, M.-H., Wu, J.-X., He, P., Bo, L., Wu, H.-Y., Lei, S.-F., & Deng, F.-Y. (2026). CRP–albumin–lymphocyte index and multisystem diseases: a phenome-wide Mendelian randomization study. Molecular Genetics and Genomics, 301(1), Article 199. https://doi.org/10.1007/s00438-026-02513-0

Image Credits: AI Generated

DOI: 10.1007/s00438-026-02513-0

Keywords: CALLY index, Mendelian randomization, PheWAS, GWAS, Alzheimer's disease, dementia, lipid metabolism, sleep disorders, inflammation, biomarkers, UK Biobank, FinnGen